Kent Corporation
2905 Highway 61 North, Muscatine, IA, 52761, United States
Overview
KENT provides corn wet milling, animal feed production, and quality food, beverage, and ingredient production, as well as agriculture and pet products. Hundreds of goods are employed as stand-alone items or as key components in hundreds of others, including livestock production, pet care, food service, consumer retail, health care, sports drinks, and spirits brands and packaging, to mention a few.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Animal Feed
- Manufacturing
- Wholesale
Investment portfolio
- Mazen Animal Health
Participated · Series A · May 2022
Mazen Animal Health is an Iowa-based startup developing oral alternatives to injectable vaccines for pigs and poultry using plants—particularly corn—as molecular farms to produce vaccine proteins. Administering vaccines in feed reduces worker exposure and labor compared with injecting animals. The company says its plant-based production is cheaper than precision fermentation in bioreactors and traditional vaccine methods. Mazen has made progress on a lead oral vaccine for Porcine Epidemic Diarrhea Virus (PEDV) and is conducting USDA-required efficacy studies. The Series A financing will be used to scale commercial manufacturing capacity and to advance a pipeline of other vaccines, including one for coccidiosis in poultry.
Team
No current team members are available.